Increases speed to market for drug developers working on nucleic acid therapeutics
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
ICMR will continue to track trends in HMPV circulation throughout the year
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Divestment is part of BASF’s strategic portfolio optimization
Exploring new opportunities within the fast-growing market of microfluidics
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
This product is categorized as antacids, antiflatulents and anti-Ulcerants
Subscribe To Our Newsletter & Stay Updated